Consistent with the analysis of the TCGA database, the group with a high TMCO3 expression in the Tongji HCC patient cohort exhibited poorer overall survival and disease‐free survival rates (Figure 8G,H). The gene discussed is SLC9D1; the disease is hepatocellular carcinoma.